AMGEN INC - 11 Jan 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Reporting relationship: 10%+ Owner
Issuer ticker: VIGL
Reported as of: 11 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jan 2022, 20:33:07 UTC
Prior SEC filing: 06 Jan 2022
Next SEC filing: 14 Sep 2023
Source filing: View source filing
Reporting owner signature: By: /s/ Andrea A. Robinson, Vice President, Law, Governance and Securities & Assistant Secretary

Key filing fact

AMGEN INC filed Form 4 for Vigil Neuroscience, Inc. (VIGL) on 11 Jan 2022.

Key facts

This page summarizes AMGEN INC's Form 4 filing for Vigil Neuroscience, Inc. (VIGL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Jan 2022, 20:33.

Change

Previous filing in this sequence was filed on 06 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIGL transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +3,206,281
Change %
Price
Shares after: 3,206,281
Date: 11 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIGL transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -3,206,281
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,206,281
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of Series A Preferred Stock were converted into shares of the Issuer's common stock on a one-for-2.7732 basis upon the completion of the Issuer's initial public offering